Trial Details
COMPLETEDBasic Information
| Clinical ID | c1470 |
|---|---|
| Identifier | NCT04993989 |
| Trial Title | A Pharmacy-based Study to Learn More About How Well Iberogast Works, How it Affects the Body, How it is Used, and User Satisfaction in Patients With Functional and Motility-related (Stomach and Bowel Movement-related) Gastrointestinal Diseases, Including Irritable Bowel Syndrome |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Functional and Motility Related Gastrointestinal Disorders Such as Irritable Bowel Syndrome and Functional Dyspepsia |
| Interventions | DRUG: Iberogast (STW5, BAY98-7411) |
Participant Information
| Sponsor | Bayer |
|---|---|
| City | Multiple Locations |
| Country/Region | Germany |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2017-11-16 |
|---|---|
| Primary Completion Date | 2018-04-18 |
| Completion Date | 2018-04-18 |